Search
for
Sort by
Research 841–870 of 894
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Real-world evidence in alopecia areata treatment: A narrative review
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Cancer-Related Alopecia Risk and Treatment
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Advancements in non-laser energy-based devices in trichology: A comprehensive review
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Latanoprost
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Hair
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia
- Animals in Dermatology
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- Autoinmune Alopecia/Alopecia Areata
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children